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Background. The intermittent preventive treatment (IPTp) policy of Malawi (2002) stipulates that IPTp is administered during 
antenatal care as a direct observation therapy (DOT). The policy further recommends that IPT should be administered monthly 
after 16 weeks of pregnancy until delivery. This study assessed both the demand and supply factors contributing to higher 
dropout of IPT after the first dose. Optimal number of doses was pegged at a minimum of three in accordance with WHO 
recommendation.  
Materials and methods. Data were analysed from the Malawi multiple indicator cluster survey (2015) and the service provision 
assessment (2014) of 6637 women (aged 15– 49 yrs), 763 facilities and 2105 health workers. The sample was made up of 
pregnant women, health facilities and workers involved in routine antenatal services across all regions of Malawi. A composite 
indicator was constructed to report integration of IPTp with ANC services and administration of IPTp-SP as DOT. Multivariate 
and logistic regression were conducted to determine associations. 
Results. Regression analysis found that: 1. Age of women (women 35–49 yrs, AOR 1.98; 95% CI 1.42 – 2.13, number of 
children as well as the number of ANC visits were associated with optimal uptake of IPTp. 2. Administering IPT as DOT was 
higher in facilities in rural areas (AOR 1.86; 95% CI 1.54 – 1.92) than in urban areas. 3. Administration of IPTp as DOT was 
relatively lower in across all facilities with highest being facilities managed by CHAM (72.8%, AOR 1.40; 95% CI 1.22 – 1.54)  
Conclusion. Health system bottlenecks were found to present the main cause of low coverage with optimal doses of IPTp. 
Incorporating these results into strategic policy IPTp formulation could help improve coverage to desired levels. This study 
could serve as plausible evidence for government and donors when planning malaria in pregnancy interventions, especially in 
remote parts of Malawi.  
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Abstract 
1 Introduction 
 
Malaria in pregnancy (MIP) poses an enormous public 
health problem that affects both the pregnant woman and 
her developing foetus. A recent systematic review and meta-
analysis of seven trials associated MIP with severe anaemia, 
cerebral malaria and low neonatal birth weight (LBW) [1]. 
Low birthweight has been identified as the greatest risk for 
neonatal mortality and is among the major contributors to 
infant mortality [2]. Out of the 25 million pregnancies at 
risk of malaria globally, 85% are found in sub-Saharan Afri-
ca [3]. This results in an average of 100,000 neonatal deaths 
and 25,000 malaria-induced maternal deaths annually [4].  
In moderate and high malaria transmission areas, WHO 
recommends intermittent preventive treatment (IPTp) for 
pregnant women during routine antenatal care (ANC) [5]. 
IPTp is a dose therapy of sulphadoxine-pyrimethamine (SP) 
administered monthly after 16 weeks of pregnancy 
(quickening) [5]. Available evidence suggests that three 
doses of SP during pregnancy are associated with fewer 
LBW (RR, 0.80; 95% CI, 0.69-0.94) [1] and lower inci-
dences of cerebral malaria [6]. Among primigravidae, three 
doses of IPTp halves the risk of LBW and significantly re-
duces the possibility of preterm birth [7]. A study in Kenya 
found that three doses of IPTp among HIV-positive preg-
nant women were associated with higher prophylactic treat-
ment against placental malaria including other pregnancy-
related acute febrile illnesses [8].  
Malawi, a high malaria transmission country, faces an 
average of 7 million malaria cases annually, which trans-
lates to 7% of all cases encountered in East- and Southern 
Africa [9]. Consequently, the Malawi Ministry of Health 
recommends a minimum of three doses of IPTp using SP 
which is to be administered as a DOT during antenatal care 
sessions [10]. While ANC attendance rate has been consid-
erably high, uptake of the optimal doses of IPTp continue to 
fall below expectation [11]. According to the Malawi De-
mographic and Health Survey (2014), whereas 50.6% preg-
nant women had attended antenatal care (ANC) at least four 
times, only 30.0% had received a minimum of three doses 
of IPTp-SP. There have been contrasting findings to explain 
this difference. Some studies suggest that demand-related 
sociodemographic factors such as age, education, income, 
wealth and occupation are the barriers that impede optimal 
uptake [12–14] whilst others identify supply issues relating 
to periodic stock-outs, confusion over correct IPTp dosing 
among health workers, along with other health system bot-
tlenecks, as key barriers [15–17]. 
In this study, both demand and supply factors were as-
sessed to determine the driving determinants of low uptake 
in Malawi. At the demand side, multivariate analysis based 
on selected sociodemographic parameters were conducted 
whereas at the supply side, the study used indicators to 
measure service integration and administration of IPTp as 
DOT. 
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2 Materials and methods 
 
2.1 Antenatal health care system in Malawi  
 
The antenatal health care system consists of three levels of 
service delivery: the primary, secondary and tertiary. The 
primary level of care is responsible for basic diagnosis and 
treatment of febrile illnesses and infectious disease control 
whilst the secondary and tertiary levels serve as referral 
points for advanced care. Under the auspices of the Ministry 
of Health, nine technical and three supportive directorates 
have been tasked with the responsibility of managing the 
health system at the national level with the district health 
management teams (DHMTs) in charge of district level ad-
ministration. Aside only 9% of its GDP being spent on 
health [18], Malawi’s healthcare is donor dependent as 68% 
of its health funding comes from international donors. This 
amounts to per capita government expenditure of US$39, 
which falls below the targets of the Abuja Declaration [20].  
 
2.2 Study population and facilities  
 
Secondary analysis of the Malawi Service Provision Assess-
ment (MSPA) [20] and the multiple indicator cluster survey 
(MICS) [21] were conducted to determine the predictors of 
uptake at the demand and supply side. Both surveys were 
nationally representative and data were collected on key 
population-based socio-demographic and health indicators.  
Given the focus of the study of demand predictors on 
IPTp uptake, 7370 women were initially selected out of the 
entire study population of 25,430. However, due to potential 
recall bias, the sample was further scaled down to include 
only women that reported IPTp uptake in two years preced-
ing the survey with all doses at the antenatal care clinics. 
Following this criterion, a sample of 6,637 women was in-
cluded in the analysis. At the supply side, analysis included 
two samples, which is the health facilities and health work-
ers. 
Out of the total 1060 health facilities in the Malawi ser-
vice provision assessment, 763 (72.0%) were selected for 
this study. The inclusion criterion for selection was health 
facilities that offered ANC services for more than one year. 
Table 1 describes the distribution of selected facilities from 
a frame of 502 Government facilities, 190 Christian Health 
Association of Malawi (CHAM) facilities, 217 private and 
Non-Governmental (NGO) facilities and 151 facilities be-
longing to companies.  
For the purpose of this study, health service workers 
were considered those that provided services relating to con-
sultation, counselling, health promotion and/or laboratory 
services. By this definition, health workers that performed 
auxiliary administrative duties were excluded. The sample 
was statistically weighed during analysis to account for over
-sampling and under-sampling of a particular cadre of staff 
in a facility or geographic area. This resulted in a sample of 
2,105 health workers out of an original total of 4,661. The 
original sampling frame comprised of 59 doctors, 980 clini-
cal technicians and medical assistants, 1,495 nurses, 35 
pharmacists, 212 anaesthetists and laboratory technicians 
and 1,880 environmental health officers and surveillance 
assistants. An inclusion criterion was that health workers 
reported that they provided antenatal care. After applying 
this criterion, only 15(0.7%) specialist medical doctors, 10 
(0.5%) clinical technicians, 84 (4.0%) medical assistants, 95 
(4.5%) registered nurse midwife, 289 (13.7%) community 
health nurse, 1196 (56.8%) enrolled midwife nurse and 416 
(19.8%) enrolled nurse midwife were included in the study.  
 
2.3 Data and data analysis 
 
Sociodemographic as well as economic variables that were 
associated with IPTp uptake were used. Wealth index, a 
composite economic indicator of socio-economic status was 
analysed as an independent variable. Similarly, other socio-
demographic variables such as level of education, regional 
province (North, South and Central), marital status and age, 
were also considered as independent unit of analysis. A pari-
ty of number of children was computed.  
Variables at the supply side included one main compo-
site indicator: IPTp administered as a direct observation 
therapy (DOT). Administration of IPTp-SP as a DOT was 
an aggregation of the following variables: availability of SP 
at the facility, qualified and trained staff to administer SP 
and SP administered to a pregnant woman in the presence of 
a health worker.  
Guided by empirical evidence [1,7] and WHO recom-
mendations on the importance of three or more doses of 
IPTp during pregnancy [5] along with Malawi’s IPTp policy 
[22], optimal uptake was computed as a minimum of three 
SP doses. Low IPTp uptake was classified as fewer than this 
recommended number of doses. Another outcome variable 
considered for observation was integration of IPT services 
within facilities offering antenatal care services. According 
to the WHO [5], an effective way to ensure receipt of IPT 
Facility type Managing authority  
  Government CHAM* NGO Company Total 
Hospital 48 43 2 0 93 
Health centre 340 108 5 7 460 
Dispensary 41 2 0 4 47 
Clinic 21 9 52 58 140 
Health post 22 1 0 0 23 
Total 472 163 59 69 763 
Table 1. Distribution of facilities by type and managing authority.  
* Christian Health Association of Malawi 
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services is via an effective integration with routine services 
during antenatal care. Integration was constructed as a com-
posite of women reported to have taken the optimal dose for 
IPT within the antenatal care facility.  
We calculated descriptive statistics of identified socio-
demographic characteristics and IPT uptake. Women were 
classified under two groups: those who took less than 3 dos-
es of IPT and those who received more during pregnancy. 
Using bivariate analysis, a test of significance was em-
ployed to assess the differences between women groups 
reported to have received IPTp 3+ and those who received 
fewer doses.  
Second, a logistic regression model was employed to 
calculate the odds with which women with these identified 
characteristics will receive IPTp. The model was adjusted 
for facility type and cadre of health worker administering 
IPT. This was to ensure that all possible cofounding was 
controlled [14]. 
At the health system side, as the main outcome of study 
was integration of IPTp with antenatal care, we constructed 
a composite indicator of facilities reported to have IPTp 
service and situated at the same site with ANC services. 
Having employed multivariate analysis, a Chi-square test 
was used to assess differences of facilities integrating IPTp 
with ANC. Finally, of the facilities reported integrating 
IPTp with ANC, we calculated health workers in those facil-
ities administering IPTp as DOT according to WHO recom-
mendation [5]. This variable was disaggregated across dif-
ferent characteristics/cadres of health workers. Another lo-
gistic regression model was then used to assess the strength 
of association between health workers’ characteristics and 
administration of IPTp as DOT. All analyses were conduct-
ed using SPSS (version 20) and MS Excel (2013). Signifi-
cance was pegged at p<0.05 (two-tailed) at 95% CI.  
 
2.4 Ethical considerations  
 
The National Health Sciences Research Committee (NHRC; 
Lilongwe, Malawi) and the macro institutional review board 
of ICF International (an international NGO in Maryland 
USA responsible for the demographic and health pro-
gramme) and UNICEF, approved the Malawi SPA and 
MICS surveys, respectively. Confidentiality of data was 
assured during data collection and likewise, this study took 
intentional steps to ensure identities of respondents were not 
revealed at any stage of analysis. Permission for this particu-
Variables n (%) of women on IPT P 
> 3 doses ≤  3 doses 
Age groups (yrs)         <0.001 
  15–24 2002 (74.6) 681 (25.4) 
25–34 2355 (79.6) 605 (20.4) 
35–49 807 (81.2) 187 (18.8) 
Education         0.234 
None 562 (77.1) 
3640 (77.4) 
894 (79.4) 
67 (85.9) 
167 (22.9) 
1063 (22.6) 
232 (20.6) 
12 (14.1) 
Primary 
Secondary 
Higher 
Wealth quintile         0.364 
Poorest 1182 (76.6) 
1182 (77.3) 
1099 (77.7) 
909 (78.8) 
792 (79.7) 
362 (23.4) 
348 (22.7) 
316 (22.3) 
245 (21.2) 
202 (20.3) 
Second 
Middle 
Fourth 
Richest 
Marital status         0.286 
Married 4379 (77.8) 
596 (79.1) 
188 (73.7) 
1249 (22.2) 
157 (20.9) 
68 (26.3) 
Divorced/Widowed 
Never married 
Region         0.041 
Northern 875 (80.5) 
1799 (76.7) 
2490 (77.7) 
212 (19.5) 
548 (23.3) 
713 (22.3) 
Central 
Southern 
Number of ANC visits     <0.001     
<4 2902 (80.9) 
2262 (74.2) 
686 (19.1) 
787 (25.8) ≥4 
Parity (# children)         <0.001 
1 46 (73.0) 
1129 (73.9) 
2932 (79.8) 
17 (27.0) 
399 (26.1) 
742 (20.2) 
2 
≥3 
Table 2. Distribution of pregnant women by socio-demographic 
characteristics and IPT uptake. 
Variable AOR 95% CI P 
Age groups (yrs)       
15–24 1.98 1.42 – 2.13 0.016 
25–34 1.54 1.22 – 1.78 
35–49 1.23 1.12 – 1.36 
Education       
None 0.92 0.75 – 1.92 0.312 
Primary 1.65 1.23 – 1.72 
Secondary 1.87 1.44 – 1.91 
Higher 1.92 1.77 – 2.01 
Wealth quintile       
Poorest 1.42 1.33 – 1.58 0.235 
Second 1.93 1.72 – 2.01 
Middle 1.55 1.43 – 1.81 
Fourth 1.87 1.35 – 1.91 
Richest 1.39 1.12 – 1.48 
Marital status       
Married 1.92 1.71 – 2.08 0.271 
Divorced/Widowed 0.93 0.72 – 1.28 
Never married 1.23 1.15 – 1.42 
Region       
Northern 1.57 1.37 – 1.72 0.022 
Central 1.16 1.02 – 1.47 
Southern 1.29 1.21 – 1.38 
Number of ANC visits       
<4 1.42 1.31 – 1.59 0.018 
≥4 1.53 1.29 – 1.82 
Parity (# children)       
1 1.12 1.09 – 1.32 0.020 
2 1.39 1.12 – 1.49 
≥3 1.45 1.26 – 1.54 
Table 3. Adjusted Odds Ratios (AOR) and 95% confidence inter-
vals (CI) of socio-demographic characteristics and uptake of IPTp 
(≥3 doses). 
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lar study was sought from DHS MEASURE Evaluation, the 
MICS team and Queen Margaret University.  
 
3 Results 
 
Tables 2 and 3 show the distribution of pregnant women 
according to socio-economic and demographic background 
as well as optimal dose intake. There was a significant rela-
tionship between age group and low uptake of IPTp as 
25.4% women aged 15–24 yrs received fewer than doses 
(AOR 1.98 95% CI 1.42–2.13) in comparison to 20.4% and 
18.8% of the women aged 25–34 yrs and 35–49 yrs, respec-
tively. In addition, women who had visited ANC a mini-
mum of four times (which is the WHO recommended mini-
mum number of visits) were less likely to take the recom-
mended doses of IPTp than those who had visited less than 
four times (AOR 1.53 95% CI 1.29–1.82). Comparing wom-
en in the regions, those in northern Malawi (AOR 1.57 95% 
CI 1.37–1.72) were more likely to obtain optimal doses than 
their counterparts in central (AOR 1.16 95% CI 1.02–1.47) 
and southern Malawi (AOR 1.29 95% CI 1.21–1.38). 
Wealth and marital status had no significant association with 
three doses of IPTp. However, surprisingly, those in second 
quintile (AOR 1.93 95% CI 1.72–2.01) were more likely to 
receive IPTp 3+ in comparison to other women in other 
wealth groups.  
Integration of IPTp services with antenatal care services 
disaggregated by selected characteristics are shown in table 
4. Multivariate analysis showed that ANC facilities in north-
ern Malawi (AOR 1.46 95% CI 1.52–1.64; Table 5) were 
more likely to administer IPTp during consultation com-
pared to central and southern Malawi (P=0.041). There was 
a significant relationship between the managing authority 
and an IPTp integrated service as private facilities were less 
likely to administer IPTp compared to facilities managed by 
other entities (P<0.001). Integration of ANC and IPTp ser-
vices were higher in central hospitals (100%), district hospi-
tals (100%), rural/community hospitals (100%) and health 
centres (97.3%). Dispensaries, however, had the least IPT 
service integrated into mainstream ANC services, as 17.6% 
had no IPTp services at the time of the assessments. There 
was a significant association between facility type (p<0.001) 
and integrated IPTp services.  
In measuring IPTp according to the recommended guide-
lines (i.e. as direct observation therapy) in table 6, it was 
found that rural facilities administered IPTp as DOT signifi-
cantly more often than urban facilities (AOR 1.86 95% CI 
1.54–1.92) (P=0.02). Additionally, staff in facilities man-
aged by CHAM were more likely to administer IPTp as 
DOT (AOR 1.40 95% CI 1.22–1.54) than facilities managed 
by other entities: Government (AOR 1.31 95% CI 1.42–
1.61), Private for profit (AOR 0.86 95% CI 0.72–0.92), Mis-
sion/Faith-based (other than CHAM) (AOR 0.98 95% CI 
0.87–1.09), NGO (AOR 1.23 95% CI 1.18–1.36) and Com-
pany (AOR 1.10 95% CI 1.02–1.29). There was a signifi-
cant association between the cadre of staff and administer-
ing IPTp-SP as a DOT (P=0.03) with the highest being reg-
istered midwives (AOR 1.89 95% CI 1.52–2.01) and spe-
cialist doctors the least (AOR 0.23 95% CI 0.13–0.58). 
 
 
 
Integration of IPTp-SP with Antenatal Services n (%) 95% CI P 
Region     0.041 
  North 115 (96.6) 92.3 – 98.7 
Central 234 (97.9) 96.2 – 98.1 
South 268 (94.0) 92.6 – 96.3 
Rural/Urban divide     0.008 
Urban 107 (91.5) 90.3 – 92.7 
Rural 510 (97.0) 96.2 – 98.1   
Facility type     <0.001 
Central hospital 4 (100) -   
District hospital 24 (100) -   
Rural/community hospital 41 (100) -   
Other hospital 31 (83.8) 81.4 – 84.9   
Health centre 440 (97.3) 96.6 – 98.2   
Maternity 3 (75.0) 73.2 – 77.4   
Dispensary 14 (82.4) 80.0 – 84.8   
Clinic 59 (95.2) 93.5 – 97.3   
Health post 1 (50.0) 45.7 – 55.6   
Managing authority     <0.001 
Government/public 396 (97.1) 96.9 – 98.1   
CHAM* 143 (97.3) 95.5 – 98.9 
Private for profit 36 (81.8) 79.2 – 83.9 
Faith-based (other than CHAM) 6 (100) - 
NGO 9 (90.0) 89.6 – 91.7 
Company 27 (96.4) 94.5 – 98.3 
Table 4. Distribution of facilities by integration of IPT services with antenatal care services.  
* Christian Health Association of Malawi 
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4 Discussion  
 
The aim of this study was to evaluate the demand and sup-
ply predictors responsible for the low uptake of intermittent 
preventive treatment in Malawi. We sought to contribute to 
the underlying complexities which continue to affect opti-
mal uptake of IPTp, especially in sub-Saharan Africa. To 
our knowledge this is the first joint analysis of SPA and 
MICS that assesses these factors in Malawi. Such an analyti-
cal approach provides a comprehensive understanding both 
from the service user and health system perspective.  
Contrary to earlier studies based on the conceptual 
framework that IPTp uptake is influenced by sociodemo-
graphic factors (i.e. education, wealth quintile, marital status 
and region of residence) [12–14], we support the paradigm 
that optimal uptake is mainly driven by health system bottle-
necks. Although findings from this study acknowledge that 
some parities such as the number of ANC visits and number 
of children were significantly associated with optimal IPTp 
uptake, we argue that the precursor to these barriers ema-
nates from existing bottlenecks arising from practices of 
healthcare providers and the health system as a whole.  
With regard to IPT administration as a DOT, we reached 
a conclusion that adherence to this protocol was generally 
lower across all facilities especially among private facilities 
(AOR 0.86 95% CI 0.72–0.92). Qualitative research con-
ducted in Nigeria reinforces these findings to further suggest 
that weak quality standards monitoring and limited capacity 
to oversee services in private facilities were the main predis-
position to compliance with this guideline [23]. Ouma et al. 
[24], in an ethnographic investigation, reported lack of 
knowledge about SP timing and confusion among health 
workers as barriers to successful compliance of the DOT 
strategy. Furthermore, Akinleye et al. [25] observed that 
although pregnant women attended ANC services and were 
willing to take SP doses, only 14.3% received supervision at 
the time of ingestion. An earlier cross-country study in 
Uganda, Tanzania and Malawi found that the absence of 
essential utilities at facilities (especially private facilities) 
such as cups were factors constraining successful optimal 
uptake. Together with our findings, we wholly support ef-
forts to train health workers especially within private facili-
ties in urban settings. In addition, we call attention of gov-
ernment actors and donors to strengthen MIP quality im-
provement and supportive supervision especially at the pri-
mary level of care.  
Integration of IPTp services with antenatal care has been 
recognised as a cost-effective mechanism to increase IPTp 
uptake as well as provide comprehensive antenatal care 
[26]. While results from our study confirm that an average 
IPTp-SP administered according to 
guidelines (DOT) 
AOR 95% CI P 
Region     0.152 
North 1.46 1.52 – 1.64 
Central 1.21 1.13 – 1.38 
South 1.08 0.91 – 1.24 
Urban/Rural divide     0.004 
Urban 1.29 1.12 – 1.52 
Rural 1.86 1.54 – 1.92 
Managing authority     0.012 
Government 1.31 1.42 – 1.61 
CHAM* 1.40 1.22 – 1.54 
Private for profit 0.86 0.72 – 0.92 
Faith-based (other than 
CHAM) 
0.98 0.87 – 1.09 
NGO 1.23 1.18 – 1.36 
Company 1.10 1.02 – 1.29 
Cadre of provider     0.038 
Specialist doctor 0.23 0.13 – 0.58 
Clinical technician 0.37 0.21 – 0.64 
Medical assistant 1.38 1.19 – 1.47 
Registered midwife 1.83 1.64 – 1.96 
Registered nurse with diploma 1.52 1.23 – 1.76 
Community health nurse 1.67 1.32 – 1.92 
Enrolled midwife/Nurse Mid-
wife Technical 
1.89 1.52 – 2.01 
Enrolled nurse midwife 1.74 1.59 – 1.88 
Sex of provider     0.721 
Male 1.56 1.32 – 1.78   
Female 1.41 1.29 – 1.71 
Table 5. Adjusted Odds Ratios (AOR) of health workers’ charac-
teristics and IPTp administration as direct observation therapy 
(DOT) in facilities reported to have integrated IPT.  
IPTp-SP administered according to 
guidelines (DOT) 
% 95% CI P 
Region     0.163 
North 74.7 70.8 – 78.3 
Central 71.0 69.3 – 71.2 
South 71.4 70.1 – 72.2 
Urban/Rural divide     0.02 
  Urban 61.0 59.3 – 62.3 
Rural 74.4 71.4 – 77.8 
Managing authority     0.01 
Government 72.1 70.9 – 74.2 
CHAM* 72.8 70.1 – 74.9 
Private for profit 50.0 45.2 – 55.3 
Faith-based (other than 
CHAM) 
57.1 55.1 – 59.5 
NGO 69.4 64.2 – 73.4 
Company 71.4 69.8 – 73.9 
Cadre of provider     0.03 
Specialist doctor 23.3 20.5 – 26.1 
Clinical technician 35.0 31.2 – 39.2 
Medical assistant 70.8 64.1 – 75.7 
Registered midwife 77.5 73.2 – 81.2 
Registered nurse with diploma 74.3 71.2 – 77.0 
Community health nurse 70.9 68.1 – 73.1 
Enrolled midwife/Nurse Mid-
wife Technical 
71.3 69.2 – 74.2 
Enrolled nurse midwife 75.1 72.8 – 78.9 
Sex of provider     0.67 
Male 72.8 70.6 – 74.2 
Female 71.3 68.2 – 75.1 
Table 6. Distribution of health staff according to administering SP 
as a direct observation therapy (DOT) where IPT is integrated with 
ANC services. 
* Christian Health Association of Malawi 
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of 67.7% of facilities integrated IPTp services with antenatal 
care, facilities managed by private entities and CHAM fell 
below this average. Integration of control of malaria in preg-
nancy services with antenatal care improves relationships 
between pregnant women and provider which eventually 
increases ANC attendance [26]. A systematic review on 
socio-cultural factors affecting uptake of MIP interventions 
in Africa confirmed this finding [17]. According to authors, 
a dominant factor that encouraged discontinuity of subse-
quent SP doses after the initial one was travelling to frag-
mented points of care for malaria in pregnancy services. 
Another meta-analysis reinforced these findings to illustrate 
how intermittent stock of SP in health centres had resulted 
to seeking care in higher level facilities [15]. The authors 
contend that inadequate transportation means together with 
high cost of travelling had given rise to higher dropout rates 
of IPTp especially in hard to reach communities. Two cross-
sectional studies funded by WHO in Tanzania partially at-
tributed these to lack of real-time health information system 
that allows health managers to respond as well as a poor 
road network [27]. To remedy this, we encourage health 
investments to be channelled to strengthening the district 
health information system (DHIS) to capture and dissemi-
nate real-time information on drug availability especially in 
hard to reach areas. 
Our study had some limitations. First, the nature of this 
study being cross-sectional limits us from claiming causali-
ty. At the demand side, the study only included respondents 
with live births two years preceding the study. Therefore, 
women that experienced perinatal death or still born were 
excluded from the study. Another source of potential bias 
was during data collection of the pregnant women. Since 
data on IPTp uptake was self-reported, it could have resulted 
to recall bias. In this instance, recall bias could result in un-
derestimating or overestimating the magnitude of IPTp up-
take. Finally, other factors were not explored as we were 
limited on the variables available in both data sets. At the 
demand side, for instance, variables such as beliefs and per-
ceptions of pregnant women and their spouses on IPTp-SP 
would have been useful in understanding context-specific 
issues that affects optimisation. In the context of these limi-
tations, we recommend that future research should focus on 
an ethnographic research to explore how women, their 
spouses and the community as a whole understand malaria 
during pregnancy and uptake of MIP interventions. 
  
5 Conclusions  
 
The lacuna in ANC coverage and IPTp uptake underscores 
missed opportunities at antenatal care in Malawi. This study 
presents another paradigm to understanding the complexity 
around low uptake in Malawi which resonates among other 
sub-Sahara African countries. Three themes emanated from 
this study: limited implementation of IPTp as DOT, low 
uptake which driven by identified health system bottlenecks 
notably low integration of IPTp with ANC services and 
higher dropouts after first due to limited service integration 
in facilities.  
While integration of IPTp with antenatal care has the 
potential to encourage future uptake, its successful achieve-
ment would depend on a strengthened health system that 
responds to stock outs in a timely manner. This implies that 
commitment to health system strengthening efforts by gov-
ernment and donors will be critical. Finally, given the rele-
vance of administering IPTp as a DOT to monitoring and 
surveillance, health authorities should continually seek to 
reinforce this through supportive quality improvement and 
providing MIP guidelines in local languages as well as pro-
moting efforts to improve service integration on the ANC 
platform. 
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